share_log

赛生药业公布授出的9万份购股权已获行使

Saisheng Pharmaceutical announced that the 90,000 share options granted have been exercised

新浪港股 ·  May 7 19:57

Saisheng Pharmaceutical (06600) announced that on May 7, 2024, according to the rules of the initial public offering after-sales share option plan: 7,000 share options granted under the initial public offering after-sales share option plan have expired; and 90,000 share options granted under the initial public offering after-sales share option plan have been exercised.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment